Primary thyroid malignancies in Tehran, Iran
- PMID: 16220012
- DOI: 10.1159/000088112
Primary thyroid malignancies in Tehran, Iran
Abstract
Objective: The aim of this study was to present a descriptive epidemiology of primary thyroid cancer in Tehran, Iran, using cancer registry data.
Subjects and methods: All cases of thyroid cancer registered from 1998 to 2001 in Tehran Metropolitan Area Population-Based Cancer Registry were used for this study. The incidence of thyroid cancer was estimated for the area covered by the cancer registry. Survival of patients was ascertained by telephone call to the patients or the patient's family and/or linkage of registry data to mortality data from the Bureau of Vital Statistics. Patient's survival was based on sex, age and morphological type of tumour.
Results: Four hundred and twenty-nine cases of primary thyroid cancer were registered in the Tehran Metropolitan Area Cancer Registry. The incidence of thyroid cancer was 3.5 and 1.0 per 100,000 population per year for females and males, respectively. Seventy percent of tumours were papillary, 11% follicular, 6.2% medullary, and the rest were other subtypes. The papillary and follicular variants occurred in younger age: 43 +/- 16 and 46 +/- 13 years, respectively; the medullary and anaplastic variants occurred in older age: over 50 years. A 5-year survival rate was 82.2%, with median survival of 66 months and 95% confidence interval of 63 and 69 months. Men and women had a similar survival experience.
Conclusions: While the incidence of thyroid cancer was slightly high, the descriptive epidemiology of thyroid cancer in Tehran did not manifest a unique feature. Tehran patients experienced a high rate of survival, and the survival time for males and females was similar.
Copyright 2005 S. Karger AG, Basel.
Similar articles
-
Changing trends in incidence and mortality of thyroid cancer in Scotland.Clin Endocrinol (Oxf). 2005 Feb;62(2):156-62. doi: 10.1111/j.1365-2265.2004.02187.x. Clin Endocrinol (Oxf). 2005. PMID: 15670190
-
Descriptive epidemiology of thyroid cancer in Osaka.Natl Cancer Inst Monogr. 1982;62:201-6. Natl Cancer Inst Monogr. 1982. PMID: 7167190
-
Thyroid malignancies: a New Zealand South Island thyroid clinic experience 1995-2006.N Z Med J. 2008 Aug 8;121(1279):36-45. N Z Med J. 2008. PMID: 18709046
-
Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001.Arch Iran Med. 2009 Jan;12(1):15-23. Arch Iran Med. 2009. PMID: 19111024
-
Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study.World J Otorhinolaryngol Head Neck Surg. 2018 Aug 11;5(1):34-40. doi: 10.1016/j.wjorl.2018.05.006. eCollection 2019 Mar. World J Otorhinolaryngol Head Neck Surg. 2018. PMID: 30775700 Free PMC article. Review.
Cited by
-
Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.Biomark Insights. 2018 Jul 2;13:1177271918785129. doi: 10.1177/1177271918785129. eCollection 2018. Biomark Insights. 2018. PMID: 30013307 Free PMC article. Review.
-
A Review of Driver Genetic Alterations in Thyroid Cancers.Iran J Pathol. 2018 Spring;13(2):125-135. Epub 2018 Jul 17. Iran J Pathol. 2018. PMID: 30697281 Free PMC article. Review.
-
Oncometabolites as biomarkers in thyroid cancer: a systematic review.Cancer Manag Res. 2019 Feb 25;11:1829-1841. doi: 10.2147/CMAR.S188661. eCollection 2019. Cancer Manag Res. 2019. PMID: 30881111 Free PMC article. Review.
-
Design and implementation of a national quality registry of thyroid cancer in Iran: study protocol.J Diabetes Metab Disord. 2023 Oct 11;23(1):1381-1386. doi: 10.1007/s40200-023-01320-3. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932868 Free PMC article.
-
The Prevalence of Thyroid Cancer in Iran: a Systematic Review and Meta-analysis.Indian J Surg Oncol. 2022 Mar;13(1):225-234. doi: 10.1007/s13193-021-01465-8. Epub 2021 Nov 12. Indian J Surg Oncol. 2022. PMID: 35462666 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous